Xeris Biopharma Secures $200M in Post-IPO Debt to Accelerate Growth in Biopharmaceuticals
By StartupChi Team | March 6, 2024
By StartupChi Team | March 6, 2024
By StartupChi Team – March 5, 2024
By StartupChi Team, March 4, 2024 Introduction
By StartupChi Team | March 1, 2024
By StartupChi Team | March 1, 2024
By StartupChi Team – February 29, 2024
Ventas Secures CA$650 Million in Post-IPO Debt
By StartupChi Team – February 29, 2024
By StartupChi Team | February 28, 2024
By StartupChi Team | February 28, 2024